日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial

copanlisib 联合 nivolumab 治疗 Richter 转化或转化型非霍奇金淋巴瘤患者的安全性和有效性:一项 I 期试验的结果

Shouse, Geoffrey; Chen, Canping; Muir, Alexandra; Popplewell, Leslie; Siddiqi, Tanya; Zain, Jasmine; Herrera, Alex F; Danilova, Olga; Roleder, Carly; Wang, Lili; Spurgeon, Stephen E F; Kittai, Adam S; Chen, Lu; Xia, Zheng; Davids, Matthew S; Danilov, Alexey V

Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022

在 RELATIVITY-022 研究中,Nivolumab 联合 relatlimab 用于治疗复发或进展性 B 细胞恶性肿瘤患者

Gopal, Ajay K; Armand, Philippe; Neelapu, Sattva S; Bartlett, Nancy L; Spurgeon, Stephen E; Kuruvilla, John; Savage, Kerry J; Leonard, John P; Gelb, Arnold B; Ahmed, Nasir; Dong, Shiqi; Bathena, Sai Praneeth; Suryawanshi, Rasika; Wu, Jenny Qun; Wang, Sheen; Gladstone, Douglas E

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

Pevonedistat(一种 Nedd8 激活酶抑制剂)与 ibrutinib 联合用于治疗复发/难治性 B 细胞非霍奇金淋巴瘤患者

Torka, Pallawi; Thiruvengadam, Swetha Kambhampati; Chen, Lu; Wang, Xiaoguang; Chen, Canping; Vuong, Dan; Qin, Hanjun; Muir, Alexandra; Orand, Kirsten; Borja, Ivana; Lynne Smith, D; Herrera, Alex F; Spurgeon, Stephen E F; Park, Byung; Lewis, Lionel D; Hernandez-Ilizaliturri, Francisco; Xia, Zheng; Danilov, Alexey V

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者对SARS-CoV-2疫苗的体液和细胞免疫反应减弱

Ujjani, Chaitra; Gooley, Ted A; Spurgeon, Stephen E; Stephens, Deborah M; Lai, Catherine; Broome, Catherine M; O'Brien, Susan; Zhu, Haiying; Laing, Kerry J; Winter, Allison M; Pongas, Georgios; Greninger, Alexander L; Koelle, David M; Siddiqi, Tanya; Davids, Matthew S; Rogers, Kerry A; Danilov, Alexey V; Sperling, Amy; Tu, Brian; Sorensen, Tyler; Launchbury, Kelsey; Burrow, Carlissa J; Quezada, Genesis; Hill, Joshua A; Shadman, Mazyar; Thompson, Philip A

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

单途径中枢神经系统预防性治疗侵袭性非霍奇金淋巴瘤:来自21家美国学术机构的真实世界结果

Orellana-Noia, Victor Manuel; Reed, Daniel R; McCook, Ashley Alesia; Sen, Jeremy Michael; Barlow, Christian M; Malecek, Mary-Kate; Watkins, Marcus; Kahl, Brad S; Spinner, Michael A; Advani, Ranjana; Voorhees, Timothy J; Snow, Anson; Grover, Natalie Sophia; Ayers, Amy; Romancik, Jason; Liu, Yuxin; Huntington, Scott F; Chavez, Julio C; Saeed, Hayder; Lazaryan, Aleksandr; Raghunathan, Vikram; Spurgeon, Stephen E; Ollila, Thomas A; Del Prete, Christopher; Olszewski, Adam; Ayers, Emily C; Landsburg, Daniel J; Echalier, Benjamin; Lee, Jun; Kamdar, Manali; Caimi, Paolo F; Fu, Timothy; Liu, Jieqi; David, Kevin A; Alharthy, Hanan; Law, Jennie; Karmali, Reem; Shah, Harsh; Stephens, Deborah M; Major, Ajay; Rojek, Alexandra E; Smith, Sonali M; Yellala, Amulya; Kallam, Avyakta; Nakhoda, Shazi; Khan, Nadia; Sohail, Mohammad Ahsan; Hill, Brian T; Barrett-Campbell, Odeth; Lansigan, Frederick; Switchenko, Jeffrey; Cohen, Jonathon; Portell, Craig A

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者接种mRNA COVID-19疫苗后的细胞和体液免疫反应

Lyski, Zoe L; Kim, Myung S; Xthona Lee, David; Raué, Hans-Peter; Raghunathan, Vikram; Griffin, Janet; Ryan, Debbie; Brunton, Amanda E; Curlin, Marcel E; Slifka, Mark K; Messer, William B; Spurgeon, Stephen E

Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia

辉瑞mRNA COVID-19疫苗接种后,再接种强生腺病毒COVID-19疫苗对两名慢性淋巴细胞白血病患者的免疫原性影响

Lyski, Zoe L; Kim, Myung Sun; Xthona Lee, David; Sampson, David; Raué, Hans-Peter; Raghunathan, Vikram; Ryan, Debbie; Brunton, Amanda E; Slifka, Mark K; Messer, William B; Spurgeon, Stephen E

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies

Entospletinib 和 obinutuzumab 用于治疗复发/难治性慢性淋巴细胞白血病和 B 细胞恶性肿瘤患者

Kittai, Adam S; Best, Scott; Thurlow, Bria; Lam, Vi; Hashiguchi, Taylor; Goodyear, Shaun; Persky, Daniel O; Okada, Craig; Park, Byung; Spurgeon, Stephen E; Danilov, Alexey V

Worsening Kidney Function, Proteinuria, and Hematuria in a Patient with CLL

慢性淋巴细胞白血病患者出现肾功能恶化、蛋白尿和血尿

Chopra, Pavan; Andeen, Nicole K; Spurgeon, Stephen E

A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia

一项Ib期、开放标签、剂量递增试验,评估抗CD37单克隆抗体BI 836826联合伊布替尼治疗复发/难治性慢性淋巴细胞白血病患者的疗效。

Danilov, Alexey V; Spurgeon, Stephen E; Siddiqi, Tanya; Quinson, Anne-Marie; Maier, Daniela; Smith, Dionne; Brown, Jennifer R